NORTHERN TRUST CORP - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$634,836
+34.1%
142,981
-0.3%
0.00%
Q2 2023$473,309
-63.3%
143,427
-68.3%
0.00%
Q1 2023$1,288,063
-54.7%
451,952
+15.7%
0.00%
-100.0%
Q4 2022$2,842,665
+12.9%
390,476
+25.4%
0.00%0.0%
Q3 2022$2,518,000
+66.8%
311,293
+1.0%
0.00%
Q2 2022$1,510,000
-75.1%
308,294
+20.0%
0.00%
-100.0%
Q1 2022$6,076,000
+30.6%
256,926
-2.3%
0.00%0.0%
Q4 2021$4,654,000
-36.0%
263,073
+2.0%
0.00%0.0%
Q3 2021$7,275,000
+218.8%
257,872
+18.4%
0.00%
Q2 2021$2,282,000
-1.8%
217,711
+10.4%
0.00%
Q1 2021$2,323,000
+4.4%
197,208
+3.8%
0.00%
Q4 2020$2,225,000
+57.5%
190,009
+6.6%
0.00%
Q3 2020$1,413,000
-53.9%
178,169
+6.4%
0.00%
-100.0%
Q2 2020$3,063,000
+91.1%
167,473
+24.7%
0.00%
Q1 2020$1,603,000
+88.8%
134,285
+163.0%
0.00%
Q4 2019$849,000
+140.5%
51,052
-4.1%
0.00%
Q3 2019$353,00053,2110.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$32,054,00014.00%
TRV GP IV, LLC 2,343,154$18,956,00011.08%
Logos Global Management LP 1,950,000$15,776,0001.94%
COWEN AND COMPANY, LLC 2,347,989$18,995,0001.82%
VR Adviser, LLC 1,200,000$9,708,0001.50%
RA Capital Management 7,000,000$56,630,0001.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,528,000$28,542,0001.18%
ACUTA CAPITAL PARTNERS, LLC 220,000$1,780,0000.77%
RTW INVESTMENTS, LP 3,985,910$32,246,0000.74%
BRANDYWINE MANAGERS, LLC 26,127$211,0000.69%
View complete list of FULCRUM THERAPEUTICS INC shareholders